drugset

drugset / Trial / NCT06036108

Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia

NCT06036108 ↗

Phase 1 Completed 59 enrolled Otsuka Pharmaceutical Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the effect of food on the pharmacokinetics of a single dose of brexpiprazole QW formulation.

Timeline

Start: 2023-10-03
Primary completion: 2025-03-18
Completion: 2025-04-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Brexpiprazole	Small molecule	48 mg	Oral

Indications